Mitch C. Hill - Jun 9, 2021 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Financial Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Stock symbol
NARI
Transactions as of
Jun 9, 2021
Transactions value $
-$449,876
Form type
4
Date filed
6/9/2021, 06:06 PM
Previous filing
May 11, 2021
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $2.29K +5K +7.36% $0.46* 72.9K Jun 9, 2021 Direct
transaction NARI Common Stock Sale -$112K -1.26K -1.72% $89.03 71.7K Jun 9, 2021 Direct F1, F2
transaction NARI Common Stock Sale -$210K -2.32K -3.24% $90.49 69.4K Jun 9, 2021 Direct F1, F3
transaction NARI Common Stock Sale -$75.2K -826 -1.19% $91.04 68.5K Jun 9, 2021 Direct F1, F4
transaction NARI Common Stock Sale -$55.4K -600 -0.88% $92.31 67.9K Jun 9, 2021 Direct F1, F5
holding NARI Common Stock 1.6K Jun 9, 2021 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to buy) Options Exercise $0 -5K -1.66% $0.00 297K Jun 9, 2021 Common Stock 5K $0.46 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $88.78 to $89.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $89.78 to $90.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $90.79 to $91.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $92.00 to $92.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 Option vested with respect to 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.